Skip to main content

and
  1. Article

    Open Access

    Author Correction: IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

    Elisa Landoni, Mark G. Woodcock, Gabriel Barragan in Nature Communications (2024)

  2. Article

    Open Access

    IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

    Human natural killer T cells (NKTs) are innate-like T lymphocytes increasingly used for cancer immunotherapy. Here we show that human NKTs expressing the pro-inflammatory cytokine interleukin-12 (IL-12) underg...

    Elisa Landoni, Mark G. Woodcock, Gabriel Barragan in Nature Communications (2024)

  3. No Access

    Article

    IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer

    Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with high resistance to therapies1. Inflammatory and immunomodulatory signals co-exist in the pancreatic tumour microenvironment, leading to dysregulate...

    Nicoletta Caronni, Federica La Terza, Francesco M. Vittoria, Giulia Barbiera in Nature (2023)

  4. Article

    Open Access

    Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia

    Acute leukemia relapsing after chemotherapy plus allogeneic hematopoietic stem cell transplantation can be treated with donor-derived T cells, but this is hampered by the need for donor/recipient MHC-matching ...

    Michela Consonni, Claudio Garavaglia, Andrea Grilli in Nature Communications (2021)

  5. Article

    Open Access

    Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

    The major cause of death after allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for acute myeloid leukemia (AML) is disease relapse. We investigated the expression of Inhibitory Receptors (IR; PD-1/CT...

    Maddalena Noviello, Francesco Manfredi, Eliana Ruggiero in Nature Communications (2019)